SEATTLE, Feb. 6 /PRNewswire/ -- Immunex Corporation (Nasdaq: IMNX) has
scheduled presentations at the following investor conferences for February
2001. The conferences, their respective dates and locations are as follows:
-- Merrill Lynch Global Pharmaceutical, Medical Device and Biotechnology
Conference
February 7, 2001
Grand Hyatt Hotel - New York, NY
-- Goldman Sachs Heart Failure Conference
February 21 - 22, 2001
Pierre Hotel - New York, NY
-- Lehman Brothers Healthcare Conference
February 27 - March 2, 2001
Grand Floridian Resort & Spa - Orlando, FL
Links to and information about webcasts and replays are available at the
Immunex website at http://www.immunex.com/investor_fs3.html
Immunex Corporation is a leading biopharmaceutical company dedicated to
improving lives through immune system science innovations.
NOTE: This news release contains forward-looking statements that involve
risks and uncertainties, including risks associated with clinical development,
regulatory approvals, our reliance on third-party manufacturers, product
commercialization and other risks described from time to time in the SEC
reports filed by Immunex, including the most recently filed Form 10-Q. An
electronic version of this news release -- as well as additional information
about Immunex of interest to investors, customers, future employees and
patients -- is available on the Immunex home page at http://www.immunex.com.
SOURCE Immunex Corporation
 back to top
Related links:
http://www.immunex.com
Company News On-Call:
http://www.prnewswire.com/comp/434644.html or fax,
800-758-5804, ext. 434644
CONTACT:
media, Kris Greco, 206-470-4871, or
investors, Mark Leahy, 206-389-4363, both of Immunex Corporation
|
